Amino Acid Metabolism Disorders Treatment Market
Market Insights on Amino Acid Metabolism Disorders Treatment covering sales outlook, demand forecast & up-to-date key trends
Amino Acid Metabolism Disorders Treatment Market By Product Type (Thiamine, Vitamin D, Betaine), Indication (Phenylketonuria, Citrullinemia, Homocystinuria), Sales Channel (Hospital Pharmacies, Retail Pharmacies) & Region - Forecast to 2017 - 2026
Introduction
Amino acids are those organic compounds that contain carboxyl (-COOH) and amine (-NH2) functional groups together with a lateral chain (R group) specific to each amino acid.
The core rudiments of an amino acid are carbon (C), oxygen (O), hydrogen (H), and nitrogen (N), though other rudiments are discovered in the side chains of some amino acids. Around 500 naturally taking place amino acids are recognized, however only 20 are visible in the genetic code, and can be segmented in countless ways.
One metabolic disorder is also associated with amino acid. Amino acids are "building blocks" that consolidate to frame proteins. In the event that one have one of these issues, the body may experience difficulty separating certain amino acids. Or on the other hand there might be an issue getting the amino acids into the cells.
These issues cause a development of destructive substances in the body. That can prompt genuine, now and again dangerous, medical issues.
These clutters are generally acquired. A child who is conceived with one might not have any indications immediately. Since the disorders can be so genuine, early analysis and treatment are basic. Infants get screened for a considerable lot of them, utilizing blood tests for bone metabolism test.
Medications may incorporate uncommon eating regimens, drugs, and supplements. A few infants may likewise require extra medicines if there are complexities.
Future Market Insights (FMI) has published a new research report on the global amino acids metabolism disorders treatment market that covers several crucial points pertaining to the growth track of the global market. Dynamics such as drivers, important trends, information about market players, restraints, strategies, product portfolio, and policies have been highlighted in the report.
The report also provides the peruser with data pertaining to the future, present, and past of the market. Data related to the regions and other segments have also been offered in the study. .
According to FMI, the global amino acid metabolism disorders treatment market is projected to rise at a stable CAGR from 2017 to 2026. The market is projected to touch a valuation of over US$1,030 Mn by the end of the forecast period
Let us know your requirement to get
100% FREE customization
North America to Lead Trailed by Europe
North America is anticipated to retain a foremost position in the market by the end of the forecast period touching a valuation of over US$359 Mn. It is expected to be closely followed by Europe.
Players operating in this market can seek potential opportunities from the U.S., Germany, Spain, and France owing to numerous clinical trials taking place pertaining to this treatment and several mergers and acquisitions occurring among core players operating in these regions.
Players can also find lucrative opportunities from Asia Pacific excluding Japan and as well with the rise in nutritional management activities in these regions. Countries in APAC such as China and India are also anticipated to emerge as potential adopters of amino acid metabolism disorders treatment in the long run.
Hospital Pharmacies to be Most Preferred Sales Channel
On the basis of sales channel, the global market for amino acid metabolism disorder treatment has been classified into hospital pharmacies, retail pharmacies, and online sales. Hospital pharmacies is expected to take the lead among all these by the end of 2026.
Based on product type, carglumic acid is expected to lead the market until the end of the forecast period reaching a valuation of over US$185 Mn. However, sapropterin dihydrocholoride is expected to witness the maximum growth rate over the course of the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCompetitive Landscape
The companies operating in the market are GlaxoSmithKline PLC, Pfizer, Inc., AMINO GmbH, Merck KGaA, Recordati S.p.A., Koninklijke DSM N.V., Sanofi, Shine Star (Hubei) Biological Engineering Co., Civentichem, LLC, Ltd., and Kyowa Hakko Kirin Co., Ltd.
Amino Acid Metabolism Disorders Treatment Market: Taxonomy
Region:
- North America
- Latin America
- Europe
- Japan
- APEJ
- MEA
Product Type:
- Arginine
- Folic Acid
- Vitamin B6 & B12
- Thiamine
- Vitamin D
- Betaine
- Carglumic Acid
- Sapropterin Dihydrochloride
- Others
Indication:
- Phenylketonuria
- Maple Syrup Urine Disease
- Argininosuccinic Acidemia
- Citrullinemia
- Homocystinuria
Sales Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Frequently Asked Questions
The amino acid metabolism disorders treatment market is anticipated to grow at 6.2% CAGR through 2032.
North America holds the biggest market space in the amino acid metabolism disorders treatment market with a valuation of over USD 359 Mn in 2022.
The amino acid metabolism disorders treatment market is estimated to surpass US$ 1.39 Bn by 2032.
The amino acid metabolism disorders treatment market size is anticipated to be over US$ 814.27 Mn in 2022.
Table of Content
1. Global Economic Outlook
2. Global Amino Acid Disorder Treatment Market - Executive Summary
3. Global Amino Acid Disorder Treatment Market Overview
3.1. Introduction
3.1.1. Global Amino Acid Disorder Treatment Market Taxonomy
3.1.2. Global Amino Acid Disorder Treatment Market Definition
3.2. Global Amino Acid Disorder Treatment Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Amino Acid Disorder Treatment Market Y-o-Y Growth
3.3. Global Amino Acid Disorder Treatment Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. Types of Amino Acid Metabolism Disorder
3.8. Epidemiology of Amino Acid Metabolism
3.9. Patent Analysis
3.10. Investment Feasibility Index
3.11. PEST Analysis
3.12. Market Positioning & Behavior Assessment
3.13. Market Competition Structure
3.14. Key Participants Market Presence (Intensity Map) By Region
4. Global Amino Acid Disorder Treatment Market Analysis and Forecast 2012-2026
4.1. Global Amino Acid Disorder Treatment Market Size and Forecast By Product Type, 2012-2026
4.1.1. Arginine Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Folic Acid Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Vitamin B6 & B12 Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Thiamine Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Vitamin D Market Size and Forecast, 2012-2026
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.1.6. Betaine Market Size and Forecast, 2012-2026
4.1.6.1. Revenue (US$ Mn) Comparison, By Region
4.1.6.2. Market Share Comparison, By Region
4.1.6.3. Y-o-Y growth Comparison, By Region
4.1.7. Carglumic Acid Market Size and Forecast, 2012-2026
4.1.7.1. Revenue (US$ Mn) Comparison, By Region
4.1.7.2. Market Share Comparison, By Region
4.1.7.3. Y-o-Y growth Comparison, By Region
4.1.8. Sapropterin Dihydrochloride Market Size and Forecast, 2012-2026
4.1.8.1. Revenue (US$ Mn) Comparison, By Region
4.1.8.2. Market Share Comparison, By Region
4.1.8.3. Y-o-Y growth Comparison, By Region
4.1.9. Others Market Size and Forecast, 2012-2026
4.1.9.1. Revenue (US$ Mn) Comparison, By Region
4.1.9.2. Market Share Comparison, By Region
4.1.9.3. Y-o-Y growth Comparison, By Region
4.2. Global Amino Acid Disorder Treatment Market Size and Forecast By Indication, 2012-2026
4.2.1. Phenylketonuria Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Maple Syrup Urine Disease Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Argininosuccinic Acidemia Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.2.4. Citrullinemia Market Size and Forecast, 2012-2026
4.2.4.1. Revenue (US$ Mn) Comparison, By Region
4.2.4.2. Market Share Comparison, By Region
4.2.4.3. Y-o-Y growth Comparison, By Region
4.2.5. Homocystinuria Market Size and Forecast, 2012-2026
4.2.5.1. Revenue (US$ Mn) Comparison, By Region
4.2.5.2. Market Share Comparison, By Region
4.2.5.3. Y-o-Y growth Comparison, By Region
4.3. Global Amino Acid Disorder Treatment Market Size and Forecast By Sales Channel, 2012-2026
4.3.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Retail Pharmacies Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Online Sales Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
5. North America Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Product Type
5.6. Revenue (US$ Mn) Comparison, By Indication
5.7. Revenue (US$ Mn) Comparison, By Sales Channel
6. Latin America Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Product Type
6.6. Revenue (US$ Mn) Comparison, By Indication
6.7. Revenue (US$ Mn) Comparison, By Sales Channel
7. Europe Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Product Type
7.6. Revenue (US$ Mn) Comparison, By Indication
7.7. Revenue (US$ Mn) Comparison, By Sales Channel
8. Japan Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Product Type
8.6. Revenue (US$ Mn) Comparison, By Indication
8.7. Revenue (US$ Mn) Comparison, By Sales Channel
9. APEJ Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Product Type
9.6. Revenue (US$ Mn) Comparison, By Indication
9.7. Revenue (US$ Mn) Comparison, By Sales Channel
10. MEA Amino Acid Disorder Treatment Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Product Type
10.6. Revenue (US$ Mn) Comparison, By Indication
10.7. Revenue (US$ Mn) Comparison, By Sales Channel
11. Global Amino Acid Disorder Treatment Market Company Share, Competition Landscape and Company Profiles
11.1. Company Market Share Analysis
11.2. Competitive Landscape
11.3. Company Profiles
11.3.1. Pfizer, Inc.
11.3.1.1. Overview
11.3.1.2. Offering Portfolio
11.3.1.3. Production Footprint
11.3.1.4. Sales Footprint
11.3.1.5. Channel Footprint
11.3.1.6. Strategy Outlook
11.3.1.7. Sales Strategy
11.3.1.8. Channel Strategy
11.3.1.9. Marketing Strategy
11.3.2. GlaxoSmithKline PLC
11.3.2.1. Overview
11.3.2.2. Offering Portfolio
11.3.2.3. Production Footprint
11.3.2.4. Sales Footprint
11.3.2.5. Channel Footprint
11.3.2.6. Strategy Outlook
11.3.2.7. Sales Strategy
11.3.2.8. Channel Strategy
11.3.2.9. Marketing Strategy
11.3.3. Merck KGaA
11.3.3.1. Overview
11.3.3.2. Offering Portfolio
11.3.3.3. Production Footprint
11.3.3.4. Sales Footprint
11.3.3.5. Channel Footprint
11.3.3.6. Strategy Outlook
11.3.3.7. Sales Strategy
11.3.3.8. Channel Strategy
11.3.3.9. Marketing Strategy
11.3.4. Koninklijke DSM N.V.
11.3.4.1. Overview
11.3.4.2. Offering Portfolio
11.3.4.3. Production Footprint
11.3.4.4. Sales Footprint
11.3.4.5. Channel Footprint
11.3.4.6. Strategy Outlook
11.3.4.7. Sales Strategy
11.3.4.8. Channel Strategy
11.3.4.9. Marketing Strategy
11.3.5. Recordati S.p.A.
11.3.5.1. Overview
11.3.5.2. Offering Portfolio
11.3.5.3. Production Footprint
11.3.5.4. Sales Footprint
11.3.5.5. Channel Footprint
11.3.5.6. S1trategy Outlook
11.3.5.7. Sales Strategy
11.3.5.8. Channel Strategy
11.3.5.9. Marketing Strategy
11.3.6. Sanofi
11.3.6.1. Overview
11.3.6.2. Offering Portfolio
11.3.6.3. Production Footprint
11.3.6.4. Sales Footprint
11.3.6.5. Channel Footprint
11.3.6.6. Strategy Outlook
11.3.6.7. Sales Strategy
11.3.6.8. Channel Strategy
11.3.6.9. Marketing Strategy
11.3.7. Civentichem, LLC
11.3.7.1. Overview
11.3.7.2. Offering Portfolio
11.3.7.3. Production Footprint
11.3.7.4. Sales Footprint
11.3.7.5. Channel Footprint
11.3.7.6. Strategy Outlook
11.3.7.7. Sales Strategy
11.3.7.8. Channel Strategy
11.3.7.9. Marketing Strategy
11.3.8. Shine Star (Hubei) Biological Engineering Co., Ltd.
11.3.8.1. Overview
11.3.8.2. Offering Portfolio
11.3.8.3. Production Footprint
11.3.8.4. Sales Footprint
11.3.8.5. Channel Footprint
11.3.8.6. Strategy Outlook
11.3.8.7. Sales Strategy
11.3.8.8. Channel Strategy
11.3.8.9. Marketing Strategy
11.3.9. AMINO GmbH
11.3.9.1. Overview
11.3.9.2. Offering Portfolio
11.3.9.3. Production Footprint
11.3.9.4. Sales Footprint
11.3.9.5. Channel Footprint
11.3.9.6. Strategy Outlook
11.3.9.7. Sales Strategy
11.3.9.8. Channel Strategy
11.3.9.9. Marketing Strategy
11.3.10. Kyowa Hakko Kirin Co., Ltd.
11.3.10.1. Overview
11.3.10.2. Offering Portfolio
11.3.10.3. Production Footprint
11.3.10.4. Sales Footprint
11.3.10.5. Channel Footprint
11.3.10.6. Strategy Outlook
11.3.10.7. Sales Strategy
11.3.10.8. Channel Strategy
11.3.10.9 Marketing Strategy
12. Research Methodology
13. Disclaimer
Let us know your requirement to get
100% FREE customization
List of Tables
TABLE 1 Global Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), 2012-2017
TABLE 2 Global Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), 2018-2026
TABLE 3 Global Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Arginine Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Arginine Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Arginine Segment Market Share, By Region 2012-2017
TABLE 7 Global Arginine Segment Market Share, By Region 2018-2026
TABLE 8 Global Arginine Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Folic Acid Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Folic Acid Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Folic Acid Segment Market Share, By Region 2012-2017
TABLE 12 Global Folic Acid Segment Market Share, By Region 2018-2026
TABLE 13 Global Folic Acid Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Vitamin B6 & B12 Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Vitamin B6 & B12 Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Vitamin B6 & B12 Segment Market Share, By Region 2012-2017
TABLE 17 Global Vitamin B6 & B12 Segment Market Share, By Region 2018-2026
TABLE 18 Global Vitamin B6 & B12 Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Thiamine Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Thiamine Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Thiamine Segment Market Share, By Region 2012-2017
TABLE 22 Global Thiamine Segment Market Share, By Region 2018-2026
TABLE 23 Global Thiamine Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Vitamin D Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Vitamin D Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Vitamin D Segment Market Share, By Region 2012-2017
TABLE 27 Global Vitamin D Segment Market Share, By Region 2018-2026
TABLE 28 Global Vitamin D Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Betaine Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Betaine Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Betaine Segment Market Share, By Region 2012-2017
TABLE 32 Global Betaine Segment Market Share, By Region 2018-2026
TABLE 33 Global Betaine Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Carglumic Acid Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Carglumic Acid Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Carglumic Acid Segment Market Share, By Region 2012-2017
TABLE 37 Global Carglumic Acid Segment Market Share, By Region 2018-2026
TABLE 38 Global Carglumic Acid Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Sapropterin Dihydrochloride Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Sapropterin Dihydrochloride Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Sapropterin Dihydrochloride Segment Market Share, By Region 2012-2017
TABLE 42 Global Sapropterin Dihydrochloride Segment Market Share, By Region 2018-2026
TABLE 43 Global Sapropterin Dihydrochloride Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Others Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Others Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Others Segment Market Share, By Region 2012-2017
TABLE 47 Global Others Segment Market Share, By Region 2018-2026
TABLE 48 Global Others Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Phenylketonuria Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Phenylketonuria Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Phenylketonuria Segment Market Share, By Region 2012-2017
TABLE 52 Global Phenylketonuria Segment Market Share, By Region 2018-2026
TABLE 53 Global Phenylketonuria Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Maple Syrup Urine Disease Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Maple Syrup Urine Disease Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Maple Syrup Urine Disease Segment Market Share, By Region 2012-2017
TABLE 57 Global Maple Syrup Urine Disease Segment Market Share, By Region 2018-2026
TABLE 58 Global Maple Syrup Urine Disease Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Argininosuccinic Acidemia Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Argininosuccinic Acidemia Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Argininosuccinic Acidemia Segment Market Share, By Region 2012-2017
TABLE 62 Global Argininosuccinic Acidemia Segment Market Share, By Region 2018-2026
TABLE 63 Global Argininosuccinic Acidemia Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Citrullinemia Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Citrullinemia Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Citrullinemia Segment Market Share, By Region 2012-2017
TABLE 67 Global Citrullinemia Segment Market Share, By Region 2018-2026
TABLE 68 Global Citrullinemia Segment Y-o-Y, By Region 2017-2026
TABLE 69 Global Homocystinuria Segment Value (US$ Mn), By Region 2012-2017
TABLE 70 Global Homocystinuria Segment Value (US$ Mn), By Region 2018-2026
TABLE 71 Global Homocystinuria Segment Market Share, By Region 2012-2017
TABLE 72 Global Homocystinuria Segment Market Share, By Region 2018-2026
TABLE 73 Global Homocystinuria Segment Y-o-Y, By Region 2017-2026
TABLE 74 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 75 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 76 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 77 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 78 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 79 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 80 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 81 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 82 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 83 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 84 Global Online Sales Segment Value (US$ Mn), By Region 2012-2017
TABLE 85 Global Online Sales Segment Value (US$ Mn), By Region 2018-2026
TABLE 86 Global Online Sales Segment Market Share, By Region 2012-2017
TABLE 87 Global Online Sales Segment Market Share, By Region 2018-2026
TABLE 88 Global Online Sales Segment Y-o-Y, By Region 2017-2026
TABLE 89 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 90 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 91 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
TABLE 92 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
TABLE 93 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 94 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 95 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 96 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 97 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 98 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 99 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
TABLE 100 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
TABLE 101 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 102 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 103 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 104 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 105 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 106 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 107 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
TABLE 108 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
TABLE 109 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 110 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 111 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 112 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 113 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 114 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 115 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
TABLE 116 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
TABLE 117 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 118 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 119 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 120 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 121 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 122 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 123 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
TABLE 124 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
TABLE 125 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 126 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 127 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 128 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 129 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 130 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 131 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
TABLE 132 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
TABLE 133 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 134 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 135 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 136 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
FIG. 1 Global Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), 2012-2017
FIG. 2 Global Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Arginine Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Arginine Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Arginine Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Folic Acid Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Folic Acid Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Folic Acid Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Vitamin B6 & B12 Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Vitamin B6 & B12 Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Vitamin B6 & B12 Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Thiamine Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Thiamine Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Thiamine Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Vitamin D Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Vitamin D Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Vitamin D Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Betaine Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Betaine Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Betaine Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Carglumic Acid Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Carglumic Acid Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Carglumic Acid Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Sapropterin Dihydrochloride Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Sapropterin Dihydrochloride Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Sapropterin Dihydrochloride Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Phenylketonuria Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Phenylketonuria Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Phenylketonuria Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Maple Syrup Urine Disease Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Maple Syrup Urine Disease Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Maple Syrup Urine Disease Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Argininosuccinic Acidemia Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Argininosuccinic Acidemia Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Argininosuccinic Acidemia Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 Global Citrullinemia Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41 Global Citrullinemia Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42 Global Citrullinemia Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43 Global Homocystinuria Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 44 Global Homocystinuria Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 45 Global Homocystinuria Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 46 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 47 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 48 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 49 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 50 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 51 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 52 Global Online Sales Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 53 Global Online Sales Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 54 Global Online Sales Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 55 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 56 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 57 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
FIG. 58 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
FIG. 59 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 60 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 61 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
FIG. 62 North America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
FIG. 63 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 64 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 65 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
FIG. 66 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
FIG. 67 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 68 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 69 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
FIG. 70 Latin America Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
FIG. 71 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 72 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 73 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
FIG. 74 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
FIG. 75 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 76 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 77 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
FIG. 78 Europe Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
FIG. 79 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 80 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 81 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
FIG. 82 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
FIG. 83 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
FIG. 84 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 85 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
FIG. 86 Japan Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
FIG. 87 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 88 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 89 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
FIG. 90 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
FIG. 91 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 92 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 93 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
FIG. 94 APEJ Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
FIG. 95 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 96 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 97 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2012-2017
FIG. 98 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Product Type 2018-2026
FIG. 99 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 100 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 101 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2012-2017
FIG. 102 MEA Amino Acid Metabolism Disorders Treatment Market Value (US$ Mn), By Sales Channel 2018-2026
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
